{
  "DOI": "10.1186/s40246-022-00384-1",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-022-00384-1",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eOsteosarcoma (OS) is the most common primary malignant bone tumor in children and young adults and has a poor prognosis. Recent developments in the field of high-throughput sequencing technology, particularly in methylated RNA immunoprecipitation sequencing (MeRIP-seq), have led to renewed interest in RNA methylation. Among the various RNA modifications, N6-methyladenosine (m6A) modifications are the most common. Emerging evidence suggests that m6A methylation can affect the complexity of cancer progression by regulating biological functions related to cancer. In this review, we will shed light on recent findings regarding the biological function of m6A methylation in OS and discuss future research directions and potential clinical applications of RNA methyltransferases in OS.\u003c/jats:p\u003e",
  "alternative-id": [
    "384"
  ],
  "article-number": "12",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "20 September 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "23 March 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "18 April 2022"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Wu",
      "given": "Yanjiao",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Wang",
      "given": "Zhiyun",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Shen",
      "given": "Jianlin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Yan",
      "given": "Wei",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Xiang",
      "given": "Shurong",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-5519-7336",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Liu",
      "given": "Huan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Huang",
      "given": "Wenhua",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2022,
        4,
        18
      ]
    ],
    "date-time": "2022-04-18T13:02:53Z",
    "timestamp": 1650286973000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        4,
        19
      ]
    ],
    "date-time": "2022-04-19T13:15:37Z",
    "timestamp": 1650374137000
  },
  "funder": [
    {
      "DOI": "10.13039/501100021171",
      "award": [
        "2019A1515111078"
      ],
      "doi-asserted-by": "crossref",
      "name": "Guangdong Basic and Applied Basic Research Foundation"
    },
    {
      "DOI": "10.13039/501100001809",
      "award": [
        "61427807"
      ],
      "doi-asserted-by": "publisher",
      "name": "National Natural Science Foundation of China"
    },
    {
      "DOI": "10.13039/501100012151",
      "award": [
        "SZSM201612019"
      ],
      "doi-asserted-by": "publisher",
      "name": "Sanming Project of Medicine in Shenzhen"
    },
    {
      "award": [
        "2012I2004"
      ],
      "name": "the Introduced Major Research and Development Project Funded by Fujian Province"
    },
    {
      "award": [
        "2018LZXNYD-ZK19"
      ],
      "name": "the Technology Strategic Cooperation Project of Southwest Medical University Science and Luzhou"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        14
      ]
    ],
    "date-time": "2024-02-14T15:39:25Z",
    "timestamp": 1707925165000
  },
  "is-referenced-by-count": 12,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2022,
        4,
        18
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2022,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            4,
            18
          ]
        ],
        "date-time": "2022-04-18T00:00:00Z",
        "timestamp": 1650240000000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            4,
            18
          ]
        ],
        "date-time": "2022-04-18T00:00:00Z",
        "timestamp": 1650240000000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-022-00384-1.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-022-00384-1/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-022-00384-1.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2022,
        4,
        18
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2022,
        4,
        18
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/j.molmed.2017.06.004",
      "author": "YH Lin",
      "doi-asserted-by": "publisher",
      "first-page": "737",
      "issue": "8",
      "journal-title": "Trends Mol Med",
      "key": "384_CR1",
      "unstructured": "Lin YH, Jewell BE, Gingold J, Lu L, Zhao R, Wang LL, et al. Osteosarcoma: molecular pathogenesis and iPSC modeling. Trends Mol Med. 2017;23(8):737–55. https://doi.org/10.1016/j.molmed.2017.06.004.",
      "volume": "23",
      "year": "2017"
    },
    {
      "DOI": "10.3390/cells10010172",
      "author": "A Smrke",
      "doi-asserted-by": "publisher",
      "first-page": "172",
      "issue": "1",
      "journal-title": "Cells-Basel",
      "key": "384_CR2",
      "unstructured": "Smrke A, Anderson PM, Gulia A, Gennatas S, Huang PH, Jones RL. Future directions in the treatment of osteosarcoma. Cells-Basel. 2021;10(1):172. https://doi.org/10.3390/cells10010172.",
      "volume": "10",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.ejca.2018.11.027",
      "author": "S Smeland",
      "doi-asserted-by": "publisher",
      "first-page": "36",
      "journal-title": "Eur J Cancer",
      "key": "384_CR3",
      "unstructured": "Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, et al. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. Eur J Cancer. 2019;109:36–50. https://doi.org/10.1016/j.ejca.2018.11.027.",
      "volume": "109",
      "year": "2019"
    },
    {
      "DOI": "10.1309/UC6K-QHLD-9LV2-KENN",
      "author": "MJ Klein",
      "doi-asserted-by": "publisher",
      "first-page": "555",
      "issue": "4",
      "journal-title": "Am J Clin Pathol",
      "key": "384_CR4",
      "unstructured": "Klein MJ, Siegal GP. Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol. 2006;125(4):555–81. https://doi.org/10.1309/UC6K-QHLD-9LV2-KENN.",
      "volume": "125",
      "year": "2006"
    },
    {
      "DOI": "10.1002/iub.2277",
      "author": "Z Jamali",
      "doi-asserted-by": "publisher",
      "first-page": "1306",
      "issue": "7",
      "journal-title": "IUBMB Life",
      "key": "384_CR5",
      "unstructured": "Jamali Z, Taheri Anganeh M, Shabaninejad Z, Keshavarzi A, Taghizadeh H, Razavi ZS, et al. Autophagy regulation bymicroRNAs: novel insights into osteosarcoma therapy. IUBMB Life. 2020;72(7):1306–21. https://doi.org/10.1002/iub.2277.",
      "volume": "72",
      "year": "2020"
    },
    {
      "DOI": "10.3390/cancers13040683",
      "author": "L Marchandet",
      "doi-asserted-by": "publisher",
      "journal-title": "Cancers",
      "key": "384_CR6",
      "unstructured": "Marchandet L, Lallier M, Charrier C, Baud’Huin M, Ory B, Lamoureux F. Mechanisms of resistance to conventional therapies for osteosarcoma. Cancers. 2021. https://doi.org/10.3390/cancers13040683.",
      "year": "2021"
    },
    {
      "DOI": "10.1080/14737140.2018.1413939",
      "author": "DJ Harrison",
      "doi-asserted-by": "publisher",
      "first-page": "39",
      "issue": "1",
      "journal-title": "Expert Rev Anticancer Ther",
      "key": "384_CR7",
      "unstructured": "Harrison DJ, Geller DS, Gill JD, Lewis VO, Gorlick R. Current and future therapeutic approaches for osteosarcoma. Expert Rev Anticancer Ther. 2018;18(1):39–50. https://doi.org/10.1080/14737140.2018.1413939.",
      "volume": "18",
      "year": "2018"
    },
    {
      "DOI": "10.1039/c6cs00599c",
      "author": "Y Chen",
      "doi-asserted-by": "publisher",
      "first-page": "2844",
      "issue": "10",
      "journal-title": "Chem Soc Rev",
      "key": "384_CR8",
      "unstructured": "Chen Y, Hong T, Wang S, Mo J, Tian T, Zhou X. Epigenetic modification of nucleic acids: from basic studies to medical applications. Chem Soc Rev. 2017;46(10):2844–72. https://doi.org/10.1039/c6cs00599c.",
      "volume": "46",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.micres.2018.10.004",
      "author": "B Wang",
      "doi-asserted-by": "publisher",
      "first-page": "101",
      "journal-title": "Microbiol Res",
      "key": "384_CR9",
      "unstructured": "Wang B, Li X, Yu D, Chen X, Tabudravu J, Deng H, et al. Deletion of the epigenetic regulator GcnE in Aspergillus niger FGSC A1279 activates the production of multiple polyketide metabolites. Microbiol Res. 2018;217:101–7. https://doi.org/10.1016/j.micres.2018.10.004.",
      "volume": "217",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.jhep.2020.04.009",
      "author": "Z Zhao",
      "doi-asserted-by": "publisher",
      "first-page": "664",
      "issue": "3",
      "journal-title": "J Hepatol",
      "key": "384_CR10",
      "unstructured": "Zhao Z, Meng J, Su R, Zhang J, Chen J, Ma X, et al. Epitranscriptomics in liver disease: basic concepts and therapeutic potential. J Hepatol. 2020;73(3):664–79. https://doi.org/10.1016/j.jhep.2020.04.009.",
      "volume": "73",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41375-021-01225-1",
      "author": "L Yao",
      "doi-asserted-by": "publisher",
      "journal-title": "Leukemia",
      "key": "384_CR11",
      "unstructured": "Yao L, Yin H, Hong M, Wang Y, Yu T, Teng Y, et al. RNA methylation in hematological malignancies and its interactions with other epigenetic modifications. Leukemia. 2021. https://doi.org/10.1038/s41375-021-01225-1.",
      "year": "2021"
    },
    {
      "DOI": "10.1093/bib/bbx142",
      "author": "X Chen",
      "doi-asserted-by": "publisher",
      "first-page": "896",
      "issue": "3",
      "journal-title": "Web Servers Comput Models",
      "key": "384_CR12",
      "unstructured": "Chen X, Sun YZ, Liu H, Zhang L, Li JQ, Meng J. RNA methylation and diseases: experimental results, databases. Web Servers Comput Models. 2019;20(3):896–917. https://doi.org/10.1093/bib/bbx142.",
      "volume": "20",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.biopha.2021.111376",
      "author": "S Komal",
      "doi-asserted-by": "publisher",
      "first-page": "111376",
      "journal-title": "Biomed Pharmacother",
      "key": "384_CR13",
      "unstructured": "Komal S, Zhang L, Han S. Potential regulatory role of epigenetic RNA methylation in cardiovascular diseases. Biomed Pharmacother. 2021;137:111376. https://doi.org/10.1016/j.biopha.2021.111376.",
      "volume": "137",
      "year": "2021"
    },
    {
      "author": "R Xu",
      "first-page": "3244",
      "issue": "236",
      "journal-title": "J Cell Physiol",
      "key": "384_CR14",
      "unstructured": "Xu R, Pang G, Zhao Q, Yang L, Chen S, Jiang L, et al. The momentous role of N6-methyladenosine in lung cancer. J Cell Physiol. 2020;5(236):3244–56.",
      "volume": "5",
      "year": "2020"
    },
    {
      "DOI": "10.3390/ijms22031474",
      "author": "Y Li",
      "doi-asserted-by": "publisher",
      "first-page": "1474",
      "issue": "3",
      "journal-title": "Int J Mol Sci",
      "key": "384_CR15",
      "unstructured": "Li Y, Qi D, Zhu B, Ye X. Analysis of m6A RNA methylation-related genes in liver hepatocellular carcinoma and their correlation with survival. Int J Mol Sci. 2021;22(3):1474. https://doi.org/10.3390/ijms22031474.",
      "volume": "22",
      "year": "2021"
    },
    {
      "DOI": "10.1186/s12935-020-01554-8",
      "author": "Z Lv",
      "doi-asserted-by": "publisher",
      "journal-title": "Cancer Cell Int",
      "key": "384_CR16",
      "unstructured": "Lv Z, Sun L, Xu Q, Xing C, Yuan Y. Joint analysis of lncRNA m6A methylome and lncRNA/mRNA expression profiles in gastric cancer. Cancer Cell Int. 2020. https://doi.org/10.1186/s12935-020-01554-8.",
      "year": "2020"
    },
    {
      "DOI": "10.1073/pnas.71.10.3971",
      "author": "R Desrosiers",
      "doi-asserted-by": "publisher",
      "first-page": "3971",
      "issue": "10",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "384_CR17",
      "unstructured": "Desrosiers R, Friderici K, Rottman F. Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci USA. 1974;71(10):3971–5. https://doi.org/10.1073/pnas.71.10.3971.",
      "volume": "71",
      "year": "1974"
    },
    {
      "DOI": "10.1016/j.biopha.2019.108613",
      "author": "T Sun",
      "doi-asserted-by": "publisher",
      "first-page": "108613",
      "journal-title": "Biomed Pharmacother",
      "key": "384_CR18",
      "unstructured": "Sun T, Wu R, Ming L. The role of m6A RNA methylation in cancer. Biomed Pharmacother. 2019;112:108613. https://doi.org/10.1016/j.biopha.2019.108613.",
      "volume": "112",
      "year": "2019"
    },
    {
      "DOI": "10.1038/nature11112",
      "author": "D Dominissini",
      "doi-asserted-by": "publisher",
      "first-page": "201",
      "issue": "7397",
      "journal-title": "Nature",
      "key": "384_CR19",
      "unstructured": "Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485(7397):201–6. https://doi.org/10.1038/nature11112.",
      "volume": "485",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.cell.2012.05.003",
      "author": "KD Meyer",
      "doi-asserted-by": "publisher",
      "first-page": "1635",
      "issue": "7",
      "journal-title": "Cell",
      "key": "384_CR20",
      "unstructured": "Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, Jaffrey SR. Comprehensive analysis of mRNA methylation reveals enrichment in 3′UTRs and near stop codons. Cell. 2012;149(7):1635–46. https://doi.org/10.1016/j.cell.2012.05.003.",
      "volume": "149",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nrg3724",
      "author": "Y Fu",
      "doi-asserted-by": "publisher",
      "first-page": "293",
      "issue": "5",
      "journal-title": "Nat Rev Genet",
      "key": "384_CR21",
      "unstructured": "Fu Y, Dominissini D, Rechavi G, He C. Gene expression regulation mediated through reversible m(6)A RNA methylation. Nat Rev Genet. 2014;15(5):293–306. https://doi.org/10.1038/nrg3724.",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.gpb.2012.12.002",
      "author": "Y Niu",
      "doi-asserted-by": "publisher",
      "first-page": "8",
      "issue": "1",
      "journal-title": "Genomics Proteomics Bioinform",
      "key": "384_CR22",
      "unstructured": "Niu Y, Zhao X, Wu Y, Li M, Wang X, Yang Y. N6-methyl-adenosine (m6A) in RNA: an Old Modification with a novel epigenetic function. Genomics Proteomics Bioinform. 2013;11(1):8–17. https://doi.org/10.1016/j.gpb.2012.12.002.",
      "volume": "11",
      "year": "2013"
    },
    {
      "DOI": "10.3389/fonc.2020.00208",
      "author": "J Du",
      "doi-asserted-by": "publisher",
      "first-page": "208",
      "journal-title": "Front Oncol",
      "key": "384_CR23",
      "unstructured": "Du J, Hou K, Mi S, Ji H, Ma S, Ba Y, et al. Malignant evaluation and clinical prognostic values of m6A RNA methylation regulators in glioblastoma. Front Oncol. 2020;10:208. https://doi.org/10.3389/fonc.2020.00208.",
      "volume": "10",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.molcel.2019.04.025",
      "author": "H Shi",
      "doi-asserted-by": "publisher",
      "first-page": "640",
      "issue": "4",
      "journal-title": "Mol Cell",
      "key": "384_CR24",
      "unstructured": "Shi H, Wei J, He C. Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers. Mol Cell. 2019;74(4):640–50. https://doi.org/10.1016/j.molcel.2019.04.025.",
      "volume": "74",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.omtn.2020.12.021",
      "author": "J Huang",
      "doi-asserted-by": "publisher",
      "first-page": "887",
      "journal-title": "Mol Ther Nucl Acids",
      "key": "384_CR25",
      "unstructured": "Huang J, Chen Z, Chen X, Chen J, Cheng Z, Wang Z. The role of RNA N6-methyladenosine methyltransferase in cancers. Mol Ther Nucl Acids. 2021;23:887–96. https://doi.org/10.1016/j.omtn.2020.12.021.",
      "volume": "23",
      "year": "2021"
    },
    {
      "DOI": "10.1002/wrna.1618",
      "author": "D Garcias Morales",
      "doi-asserted-by": "publisher",
      "journal-title": "WIREs RNA",
      "key": "384_CR26",
      "unstructured": "Garcias Morales D, Reyes JL. A birds’-eye view of the activity and specificity of the mRNA m6A methyltransferase complex. WIREs RNA. 2021. https://doi.org/10.1002/wrna.1618.",
      "year": "2021"
    },
    {
      "DOI": "10.1007/s00239-002-2339-8",
      "author": "JM Bujnicki",
      "doi-asserted-by": "publisher",
      "first-page": "431",
      "issue": "4",
      "journal-title": "J Mol Evol",
      "key": "384_CR27",
      "unstructured": "Bujnicki JM, Feder M, Radlinska M, Blumenthal RM. Structure prediction and phylogenetic analysis of a functionally diverse family of proteins homologous to the MT-A70 subunit of the human mRNA:m(6)A methyltransferase. J Mol Evol. 2002;55(4):431–44. https://doi.org/10.1007/s00239-002-2339-8.",
      "volume": "55",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S0021-9258(17)32497-3",
      "author": "JA Bokar",
      "doi-asserted-by": "publisher",
      "first-page": "17697",
      "issue": "26",
      "journal-title": "J Biol Chem",
      "key": "384_CR28",
      "unstructured": "Bokar JA, Rath-Shambaugh ME, Ludwiczak R, Narayan P, Rottman F. Characterization and partial purification of mRNA N6-adenosine methyltransferase from HeLa cell nuclei: internal mRNA methylation requires a multisubunit complex. J Biol Chem. 1994;269(26):17697–704.",
      "volume": "269",
      "year": "1994"
    },
    {
      "DOI": "10.1042/bj2880233",
      "author": "MT Tuck",
      "doi-asserted-by": "publisher",
      "first-page": "233",
      "issue": "Pt 1",
      "journal-title": "Biochem J",
      "key": "384_CR29",
      "unstructured": "Tuck MT. Partial purification of a 6-methyladenine mRNA methyltransferase which modifies internal adenine residues. Biochem J. 1992;288(Pt 1):233–40. https://doi.org/10.1042/bj2880233.",
      "volume": "288",
      "year": "1992"
    },
    {
      "DOI": "10.1016/j.molcel.2016.05.041",
      "author": "P Wang",
      "doi-asserted-by": "publisher",
      "first-page": "306",
      "issue": "2",
      "journal-title": "Mol Cell",
      "key": "384_CR30",
      "unstructured": "Wang P, Doxtader KA, Nam Y. Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases. Mol Cell. 2016;63(2):306–17. https://doi.org/10.1016/j.molcel.2016.05.041.",
      "volume": "63",
      "year": "2016"
    },
    {
      "DOI": "10.1038/nchembio.1432",
      "author": "J Liu",
      "doi-asserted-by": "publisher",
      "first-page": "93",
      "issue": "2",
      "journal-title": "Nat Chem Biol",
      "key": "384_CR31",
      "unstructured": "Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, et al. A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10(2):93–5. https://doi.org/10.1038/nchembio.1432.",
      "volume": "10",
      "year": "2014"
    },
    {
      "DOI": "10.1038/cr.2014.3",
      "author": "PBSL Xiao-Li",
      "doi-asserted-by": "publisher",
      "first-page": "177",
      "issue": "2",
      "journal-title": "Cell Res",
      "key": "384_CR32",
      "unstructured": "Xiao-Li PBSL. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 2014;24(2):177–89. https://doi.org/10.1038/cr.2014.3.",
      "volume": "24",
      "year": "2014"
    },
    {
      "DOI": "10.1038/s41421-018-0019-0",
      "author": "Y Yue",
      "doi-asserted-by": "publisher",
      "first-page": "10",
      "journal-title": "Cell Discov",
      "key": "384_CR33",
      "unstructured": "Yue Y, Liu J, Cui X, Cao J, Luo G, Zhang Z, et al. VIRMA mediates preferential m(6)A mRNA methylation in 3’UTR and near stop codon and associates with alternative polyadenylation. Cell Discov. 2018;4:10. https://doi.org/10.1038/s41421-018-0019-0.",
      "volume": "4",
      "year": "2018"
    },
    {
      "DOI": "10.1038/nchembio.687",
      "author": "G Jia",
      "doi-asserted-by": "publisher",
      "first-page": "885",
      "issue": "12",
      "journal-title": "Nat Chem Biol",
      "key": "384_CR34",
      "unstructured": "Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, et al. N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7(12):885–7. https://doi.org/10.1038/nchembio.687.",
      "volume": "7",
      "year": "2011"
    },
    {
      "DOI": "10.1038/ncomms2822",
      "author": "Y Fu",
      "doi-asserted-by": "publisher",
      "journal-title": "Nat Commun",
      "key": "384_CR35",
      "unstructured": "Fu Y, Jia G, Pang X, Wang RN, Wang X, Li CJ, et al. FTO-mediated formation of N6-hydroxymethyladenosine and N6-formyladenosine in mammalian RNA. Nat Commun. 2013. https://doi.org/10.1038/ncomms2822.",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.molcel.2012.10.015",
      "author": "G Zheng",
      "doi-asserted-by": "publisher",
      "first-page": "18",
      "issue": "1",
      "journal-title": "Mol Cell",
      "key": "384_CR36",
      "unstructured": "Zheng G, Dahl JA, Niu Y, Fedorcsak P, Huang C, Li CJ, et al. ALKBH5 Is a mammalian RNA Demethylase that impacts RNA metabolism and mouse fertility. Mol Cell. 2013;49(1):18–29. https://doi.org/10.1016/j.molcel.2012.10.015.",
      "volume": "49",
      "year": "2013"
    },
    {
      "DOI": "10.3389/fonc.2021.629560",
      "author": "Y Xu",
      "doi-asserted-by": "publisher",
      "journal-title": "Front Oncol",
      "key": "384_CR37",
      "unstructured": "Xu Y, Zhang W, Shen F, Yang X, Liu H, Dai S, et al. YTH domain proteins: a family of m6A readers in cancer progression. Front Oncol. 2021. https://doi.org/10.3389/fonc.2021.629560.",
      "year": "2021"
    },
    {
      "DOI": "10.7554/eLife.31311",
      "author": "IA Roundtree",
      "doi-asserted-by": "publisher",
      "journal-title": "Elife",
      "key": "384_CR38",
      "unstructured": "Roundtree IA, Luo GZ, Zhang Z, Wang X, Zhou T, Cui Y, et al. YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs. Elife. 2017. https://doi.org/10.7554/eLife.31311.",
      "year": "2017"
    },
    {
      "DOI": "10.1371/journal.pgen.1007412",
      "author": "SD Kasowitz",
      "doi-asserted-by": "publisher",
      "first-page": "e1007412",
      "issue": "5",
      "journal-title": "Plos Genet",
      "key": "384_CR39",
      "unstructured": "Kasowitz SD, Ma J, Anderson SJ, Leu NA, Xu Y, Gregory BD, et al. Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development. Plos Genet. 2018;14(5):e1007412. https://doi.org/10.1371/journal.pgen.1007412.",
      "volume": "14",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.omtn.2020.09.036",
      "author": "X Liu",
      "doi-asserted-by": "publisher",
      "first-page": "750",
      "journal-title": "Mol Ther Nucleic Acids",
      "key": "384_CR40",
      "unstructured": "Liu X, Qin J, Gao T, Li C, He B, Pan B, et al. YTHDF1 Facilitates the progression of hepatocellular carcinoma by promoting FZD5 mRNA translation in an m6A-dependent manner. Mol Ther Nucleic Acids. 2020;22:750–65. https://doi.org/10.1016/j.omtn.2020.09.036.",
      "volume": "22",
      "year": "2020"
    },
    {
      "DOI": "10.1002/hep.29683",
      "author": "M Chen",
      "doi-asserted-by": "publisher",
      "first-page": "2254",
      "issue": "6",
      "journal-title": "Hepatology",
      "key": "384_CR41",
      "unstructured": "Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 2018;67(6):2254–70. https://doi.org/10.1002/hep.29683.",
      "volume": "67",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.ccell.2020.10.004",
      "author": "G Chang",
      "doi-asserted-by": "publisher",
      "first-page": "857",
      "issue": "6",
      "journal-title": "Cancer Cell",
      "key": "384_CR42",
      "unstructured": "Chang G, Shi L, Ye Y, Shi H, Zeng L, Tiwary S, et al. YTHDF3 induces the translation of m(6)A-enriched gene transcripts to promote breast cancer brain metastasis. Cancer Cell. 2020;38(6):857–71. https://doi.org/10.1016/j.ccell.2020.10.004.",
      "volume": "38",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.redox.2020.101801",
      "author": "L Ma",
      "doi-asserted-by": "publisher",
      "first-page": "101801",
      "journal-title": "Redox Biol",
      "key": "384_CR43",
      "unstructured": "Ma L, Chen T, Zhang X, Miao Y, Tian X, Yu K, et al. The m(6)A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function. Redox Biol. 2021;38:101801. https://doi.org/10.1016/j.redox.2020.101801.",
      "volume": "38",
      "year": "2021"
    },
    {
      "DOI": "10.3389/fonc.2021.632934",
      "author": "Y Pan",
      "doi-asserted-by": "publisher",
      "first-page": "632934",
      "journal-title": "Front Oncol",
      "key": "384_CR44",
      "unstructured": "Pan Y, Xiao K, Li Y, Li Y, Liu Q. RNA N6-methyladenosine regulator-mediated methylation modifications pattern and immune infiltration features in glioblastoma. Front Oncol. 2021;11:632934. https://doi.org/10.3389/fonc.2021.632934.",
      "volume": "11",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41556-018-0045-z",
      "author": "H Huang",
      "doi-asserted-by": "publisher",
      "first-page": "285",
      "issue": "3",
      "journal-title": "Nat Cell Biol",
      "key": "384_CR45",
      "unstructured": "Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20(3):285–95. https://doi.org/10.1038/s41556-018-0045-z.",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41467-020-15403-9",
      "doi-asserted-by": "publisher",
      "key": "384_CR46",
      "unstructured": "Zhu S, Wang JZ, Chen, He YT, Meng N, Chen M, et al. An oncopeptide regulates m(6)A recognition by the m(6)A reader IGF2BP1 and tumorigenesis. Nat Commun. 2020;11(1):1685. https://doi.org/10.1038/s41467-020-15403-9"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-20-1619",
      "author": "S Gao",
      "doi-asserted-by": "publisher",
      "journal-title": "Cancer Res",
      "key": "384_CR47",
      "unstructured": "Gao S, Gu Y, Niu S, Wang Y, Duan L, Pan Y, et al. DMDRMR-mediated regulation of m6A-modified CDK4 by m6A reader IGF2BP3 drives ccRCC progression. Cancer Res. 2020. https://doi.org/10.1158/0008-5472.CAN-20-1619.",
      "year": "2020"
    },
    {
      "DOI": "10.3389/fonc.2020.536875",
      "author": "LC Wang",
      "doi-asserted-by": "publisher",
      "first-page": "536875",
      "journal-title": "Front Oncol",
      "key": "384_CR48",
      "unstructured": "Wang LC, Chen SH, Shen XL, Li DC, Liu HY, Ji YL, et al. M6A RNA methylation regulator HNRNPC contributes to tumorigenesis and predicts prognosis in glioblastoma multiforme. Front Oncol. 2020;10:536875. https://doi.org/10.3389/fonc.2020.536875.",
      "volume": "10",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41598-019-45636-8",
      "author": "CM Klinge",
      "doi-asserted-by": "publisher",
      "first-page": "9430",
      "issue": "1",
      "journal-title": "Sci Rep",
      "key": "384_CR49",
      "unstructured": "Klinge CM, Piell KM, Tooley CS, Rouchka EC. HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells. Sci Rep. 2019;9(1):9430. https://doi.org/10.1038/s41598-019-45636-8.",
      "volume": "9",
      "year": "2019"
    },
    {
      "DOI": "10.1038/35077213",
      "author": "GI Evan",
      "doi-asserted-by": "publisher",
      "first-page": "342",
      "issue": "6835",
      "journal-title": "Nature",
      "key": "384_CR50",
      "unstructured": "Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411(6835):342–8. https://doi.org/10.1038/35077213.",
      "volume": "411",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.biopha.2020.109964",
      "author": "L Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "109964",
      "journal-title": "Biomed Pharmacother",
      "key": "384_CR51",
      "unstructured": "Zhou L, Yang C, Zhang N, Zhang X, Zhao T, Yu J. Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2. Biomed Pharmacother. 2020;125:109964. https://doi.org/10.1016/j.biopha.2020.109964.",
      "volume": "125",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.bbrc.2019.06.128",
      "author": "W Miao",
      "doi-asserted-by": "publisher",
      "first-page": "719",
      "issue": "3",
      "journal-title": "Biochem Bioph Res Co",
      "key": "384_CR52",
      "unstructured": "Miao W, Chen J, Jia L, Ma J, Song D. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1. Biochem Bioph Res Co. 2019;516(3):719–25. https://doi.org/10.1016/j.bbrc.2019.06.128.",
      "volume": "516",
      "year": "2019"
    },
    {
      "DOI": "10.1042/BSR20200282",
      "author": "Z Ling",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "4",
      "journal-title": "Biosci Rep",
      "key": "384_CR53",
      "unstructured": "Ling Z, Chen L. Zhao J (2020) m6A-dependent up-regulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma. Biosci Rep. 2020;40(4):1.",
      "volume": "40",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s12935-020-1105-6",
      "author": "S Chen",
      "doi-asserted-by": "publisher",
      "journal-title": "Cancer Cell Int",
      "key": "384_CR54",
      "unstructured": "Chen S, Zhou L, Wang Y. ALKBH5-mediated m6A demethylation of lncRNA PVT1 plays an oncogenic role in osteosarcoma. Cancer Cell Int. 2020. https://doi.org/10.1186/s12935-020-1105-6.",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41419-020-02847-6",
      "author": "S Chen",
      "doi-asserted-by": "publisher",
      "journal-title": "Cell Death Dis",
      "key": "384_CR55",
      "unstructured": "Chen S, Li Y, Zhi S, Ding Z, Wang W, Peng Y, et al. WTAP promotes osteosarcoma tumorigenesis by repressing HMBOX1 expression in an m6A-dependent manner. Cell Death Dis. 2020. https://doi.org/10.1038/s41419-020-02847-6.",
      "year": "2020"
    },
    {
      "DOI": "10.1080/15384101.2020.1749465",
      "author": "Q Han",
      "doi-asserted-by": "publisher",
      "first-page": "1172",
      "issue": "10",
      "journal-title": "Cell Cycle",
      "key": "384_CR56",
      "unstructured": "Han Q, Yang J, Yang H, Li C, Li J, Cao Y. KIAA1429 promotes osteosarcoma progression by promoting stem cell properties and is regulated by miR-143-3p. Cell Cycle. 2020;19(10):1172–85. https://doi.org/10.1080/15384101.2020.1749465.",
      "volume": "19",
      "year": "2020"
    },
    {
      "DOI": "10.2147/OTT.S234668",
      "author": "Y Jie",
      "doi-asserted-by": "publisher",
      "first-page": "1723",
      "journal-title": "Expression",
      "key": "384_CR57",
      "unstructured": "Jie Y, Han Q, Li C, Yang H, Chen X, Wang X. Circular RNA circ_0001105 inhibits progression and metastasis of osteosarcoma by sponging miR-766 and activating YTHDF2. Expression. 2020;13:1723–36. https://doi.org/10.2147/OTT.S234668.",
      "volume": "13",
      "year": "2020"
    },
    {
      "DOI": "10.1002/wnan.1698",
      "author": "H Yang",
      "doi-asserted-by": "publisher",
      "journal-title": "WIREs Nanomed Nanobiotechnol",
      "key": "384_CR58",
      "unstructured": "Yang H, Kuo YH, Smith ZI, Spangler J. Targeting cancer metastasis with antibody therapeutics. WIREs Nanomed Nanobiotechnol. 2021. https://doi.org/10.1002/wnan.1698.",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.ebiom.2020.102955",
      "author": "C Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "102955",
      "journal-title": "EBioMedicine",
      "key": "384_CR59",
      "unstructured": "Zhou C, Zhang Z, Zhu X, Qian G, Zhou Y, Sun Y, et al. N6-Methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1. EBioMedicine. 2020;59:102955. https://doi.org/10.1016/j.ebiom.2020.102955.",
      "volume": "59",
      "year": "2020"
    },
    {
      "DOI": "10.3389/fonc.2020.00769",
      "author": "J Li",
      "doi-asserted-by": "publisher",
      "journal-title": "Front Oncol",
      "key": "384_CR60",
      "unstructured": "Li J, Rao B, Yang J, Liu L, Huang M, Liu X, et al. Dysregulated m6A-related regulators are associated with tumor metastasis and poor prognosis in osteosarcoma. Front Oncol. 2020. https://doi.org/10.3389/fonc.2020.00769.",
      "year": "2020"
    },
    {
      "DOI": "10.2217/epi-2019-0262",
      "author": "Y Wang",
      "doi-asserted-by": "publisher",
      "first-page": "1693",
      "issue": "15",
      "journal-title": "Epigenomics-UK",
      "key": "384_CR61",
      "unstructured": "Wang Y, Zeng L, Liang C, Zan R, Ji W, Zhang Z, et al. Integrated analysis of transcriptome-wide m6A methylome of osteosarcoma stem cells enriched by chemotherapy. Epigenomics-UK. 2019;11(15):1693–715. https://doi.org/10.2217/epi-2019-0262.",
      "volume": "11",
      "year": "2019"
    },
    {
      "DOI": "10.1002/adma.202004788",
      "author": "M Chang",
      "doi-asserted-by": "publisher",
      "first-page": "e2004788",
      "issue": "4",
      "journal-title": "Adv Mater",
      "key": "384_CR62",
      "unstructured": "Chang M, Hou Z, Wang M, Li C, Lin J. Recent advances in hyperthermia therapy-based synergistic immunotherapy. Adv Mater. 2021;33(4):e2004788. https://doi.org/10.1002/adma.202004788.",
      "volume": "33",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.semcancer.2018.11.006",
      "author": "TB Steinbichler",
      "doi-asserted-by": "publisher",
      "first-page": "156",
      "journal-title": "Semin Cancer Biol",
      "key": "384_CR63",
      "unstructured": "Steinbichler TB, Dudas J, Skvortsov S, Ganswindt U, Riechelmann H, Skvortsova II. Therapy resistance mediated by cancer stem cells. Semin Cancer Biol. 2018;53:156–67. https://doi.org/10.1016/j.semcancer.2018.11.006.",
      "volume": "53",
      "year": "2018"
    },
    {
      "DOI": "10.1038/nature21671",
      "author": "Y Xiang",
      "doi-asserted-by": "publisher",
      "first-page": "573",
      "issue": "7646",
      "journal-title": "Nature",
      "key": "384_CR64",
      "unstructured": "Xiang Y, Laurent B, Hsu C, Nachtergaele S, Lu Z, Sheng W, et al. RNA m6A methylation regulates the ultraviolet-induced DNA damage response. Nature. 2017;543(7646):573–6. https://doi.org/10.1038/nature21671.",
      "volume": "543",
      "year": "2017"
    },
    {
      "DOI": "10.1186/s13578-020-00502-3",
      "author": "Y Wang",
      "doi-asserted-by": "publisher",
      "journal-title": "Cell Biosci",
      "key": "384_CR65",
      "unstructured": "Wang Y, Zhang Y, Du Y, Zhou M, Hu Y, Zhang S. Emerging roles of N6-methyladenosine (m6A) modification in breast cancer. Cell Biosci. 2020. https://doi.org/10.1186/s13578-020-00502-3.",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s12943-019-1109-9",
      "author": "L He",
      "doi-asserted-by": "publisher",
      "first-page": "176",
      "issue": "1",
      "journal-title": "Mol Cancer",
      "key": "384_CR66",
      "unstructured": "He L, Li H, Wu A, Peng Y, Shu G, Yin G. Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019;18(1):176. https://doi.org/10.1186/s12943-019-1109-9.",
      "volume": "18",
      "year": "2019"
    },
    {
      "DOI": "10.1186/s12943-020-01207-4",
      "author": "Y Chen",
      "doi-asserted-by": "publisher",
      "journal-title": "Mol Cancer",
      "key": "384_CR67",
      "unstructured": "Chen Y, Lin Y, Shu Y, He J, Gao W. Interaction between N6-methyladenosine (m6A) modification and noncoding RNAs in cancer. Mol Cancer. 2020. https://doi.org/10.1186/s12943-020-01207-4.",
      "year": "2020"
    },
    {
      "DOI": "10.1186/s13046-020-01706-8",
      "author": "Y Zhang",
      "doi-asserted-by": "publisher",
      "journal-title": "J Exp Clin Canc Res.",
      "key": "384_CR68",
      "unstructured": "Zhang Y, Geng X, Li Q, Xu J, Tan Y, Xiao M, et al. m6A modification in RNA: biogenesis, functions and roles in gliomas. J Exp Clin Canc Res. 2020. https://doi.org/10.1186/s13046-020-01706-8.",
      "year": "2020"
    },
    {
      "DOI": "10.7150/thno.52366",
      "author": "J Li",
      "doi-asserted-by": "publisher",
      "first-page": "2581",
      "issue": "6",
      "journal-title": "Theranostics",
      "key": "384_CR69",
      "unstructured": "Li J, Liang L, Yang Y, Li X, Ma Y. N6-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction. Theranostics. 2021;11(6):2581–93. https://doi.org/10.7150/thno.52366.",
      "volume": "11",
      "year": "2021"
    },
    {
      "DOI": "10.1186/s12943-020-01204-7",
      "author": "T Wang",
      "doi-asserted-by": "publisher",
      "journal-title": "Mol Cancer",
      "key": "384_CR70",
      "unstructured": "Wang T, Kong S, Tao M, Ju S. The potential role of RNA N6-methyladenosine in Cancer progression. Mol Cancer. 2020. https://doi.org/10.1186/s12943-020-01204-7.",
      "year": "2020"
    },
    {
      "DOI": "10.3389/fcell.2020.579919",
      "author": "Y Li",
      "doi-asserted-by": "publisher",
      "first-page": "579919",
      "journal-title": "Front Cell Dev Biol",
      "key": "384_CR71",
      "unstructured": "Li Y, Ge Y, Xu L, Xu Z, Dou Q, Jia R. The potential roles of RNA N6-methyladenosine in urological tumors. Front Cell Dev Biol. 2020;8:579919. https://doi.org/10.3389/fcell.2020.579919.",
      "volume": "8",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41419-020-03315-x",
      "author": "Y Yuan",
      "doi-asserted-by": "publisher",
      "journal-title": "Cell Death Dis",
      "key": "384_CR72",
      "unstructured": "Yuan Y, Yan G, He M, Lei H, Li L, Wang Y, et al. ALKBH5 suppresses tumor progression via an m6A-dependent epigenetic silencing of pre-miR-181b-1/YAP signaling axis in osteosarcoma. Cell Death Dis. 2021. https://doi.org/10.1038/s41419-020-03315-x.",
      "year": "2021"
    },
    {
      "DOI": "10.1186/s12943-019-1099-7",
      "author": "B Hu",
      "doi-asserted-by": "publisher",
      "journal-title": "Mol Cancer",
      "key": "384_CR73",
      "unstructured": "Hu B, Wang X, Gu X, Zou C, Gao Z, Zhang H, et al. N6-methyladenosine (m6A) RNA modification in gastrointestinal tract cancers: roles, mechanisms, and applications. Mol Cancer. 2019. https://doi.org/10.1186/s12943-019-1099-7.",
      "year": "2019"
    },
    {
      "DOI": "10.1186/s12943-019-1038-7",
      "author": "T Li",
      "doi-asserted-by": "publisher",
      "first-page": "112",
      "issue": "1",
      "journal-title": "Mol Cancer",
      "key": "384_CR74",
      "unstructured": "Li T, Hu PS, Zuo Z, Lin JF, Li X, Wu QN, et al. METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mechanism in colorectal carcinoma. Mol Cancer. 2019;18(1):112. https://doi.org/10.1186/s12943-019-1038-7.",
      "volume": "18",
      "year": "2019"
    },
    {
      "DOI": "10.2147/OTT.S201052",
      "author": "R Deng",
      "doi-asserted-by": "publisher",
      "first-page": "4391",
      "journal-title": "Oncol Targets Ther",
      "key": "384_CR75",
      "unstructured": "Deng R, Cheng Y, Ye S, Zhang J, Huang R, Li P, et al. m(6)A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways. Oncol Targets Ther. 2019;12:4391–402. https://doi.org/10.2147/OTT.S201052.",
      "volume": "12",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41588-021-00890-3",
      "author": "X Xiong",
      "doi-asserted-by": "publisher",
      "first-page": "1156",
      "issue": "8",
      "journal-title": "Nat Genet",
      "key": "384_CR76",
      "unstructured": "Xiong X, Hou L, Park YP, Molinie B, Gregory RI, Kellis M. Genetic drivers of m(6)A methylation in human brain, lung, heart and muscle. Nat Genet. 2021;53(8):1156–65. https://doi.org/10.1038/s41588-021-00890-3.",
      "volume": "53",
      "year": "2021"
    },
    {
      "DOI": "10.1093/nar/gkaa347",
      "author": "H Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "6251",
      "issue": "11",
      "journal-title": "Nucleic Acids Res",
      "key": "384_CR77",
      "unstructured": "Zhang H, Shi X, Huang T, Zhao X, Chen W, Gu N, et al. Dynamic landscape and evolution of m6A methylation in human. Nucleic Acids Res. 2020;48(11):6251–64. https://doi.org/10.1093/nar/gkaa347.",
      "volume": "48",
      "year": "2020"
    }
  ],
  "reference-count": 77,
  "references-count": 77,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-022-00384-1"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "The role of m6A methylation in osteosarcoma biological processes and its potential clinical value"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "16"
}